Free Trial

Janux Therapeutics (JANX) Stock Forecast & Price Target

Janux Therapeutics logo
$14.19 +0.01 (+0.07%)
As of 12:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Janux Therapeutics - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
3
Buy
10

Based on 15 Wall Street analysts who have issued ratings for Janux Therapeutics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 2 have given a sell rating, 3 have given a hold rating, 9 have given a buy rating, and 1 has given a strong buy rating for JANX.

Consensus Price Target

$45.85
223.09% Upside
According to the 15 analysts' twelve-month price targets for Janux Therapeutics, the average price target is $45.85. The highest price target for JANX is $100.00, while the lowest price target for JANX is $14.00. The average price target represents a forecasted upside of 223.09% from the current price of $14.19.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for JANX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Janux Therapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JANX Analyst Ratings Over Time

TypeCurrent Forecast
5/11/25 to 5/11/26
1 Month Ago
4/11/25 to 4/11/26
3 Months Ago
2/10/25 to 2/10/26
1 Year Ago
5/11/24 to 5/11/25
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
9 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
8 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$45.85$56.91$60.08$95.25
Forecasted Upside223.09% Upside281.17% Upside357.60% Upside272.65% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyBuy

JANX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

JANX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Janux Therapeutics Stock vs. The Competition

TypeJanux TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
2.60
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside237.33% Upside858.41% Upside15.49% Upside
News Sentiment Rating
Neutral News

See Recent JANX News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/8/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
Lower TargetOverweight$30.00 ➝ $26.00+83.84%
5/8/2026
Wedbush logo
Wedbush
5 of 5 stars
Robert Driscoll
Robert Driscoll
5 of 5 stars
Lower TargetOutperform$45.00 ➝ $36.00+151.84%
5/8/2026
Guggenheim logo
Guggenheim
5 of 5 stars
Brad Canino
Brad Canino
Not Rated
Lower TargetBuy$68.00 ➝ $58.00+298.90%
5/4/2026 UpgradeStrong-Buy
4/28/2026Lower TargetBuy$50.00 ➝ $28.00+94.92%
4/22/2026 UpgradeSell (E+)Sell (D-)
4/20/2026DowngradeOverweightUnderweight$29.00 ➝ $14.00-11.50%
4/15/2026DowngradeBuyNeutral$57.00 ➝ $15.00-1.57%
2/27/2026Lower TargetOverweight$150.00 ➝ $100.00+639.97%
1/20/2026 DowngradeStrong-BuyHold
12/2/2025Lower TargetBuy$46.00 ➝ $38.00+11.80%
12/2/2025Lower TargetBuy$70.00 ➝ $45.00+32.39%
12/2/2025Lower TargetBuy$58.00 ➝ $49.00+44.16%
11/18/2025Initiated CoveragePeer Perform
7/11/2025Initiated CoverageOutperform$65.00+153.81%
2/28/2025Lower TargetSector Perform$62.00 ➝ $41.00+24.66%
1/10/2025 Reiterated RatingOutperform
12/27/2024UpgradeStrong-Buy
12/3/2024 Boost TargetOutperform$79.00 ➝ $91.00+46.09%
12/3/2024 Boost TargetBuy$82.00 ➝ $100.00+148.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:56 PM ET.


JANX Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Janux Therapeutics is $45.85, with a high forecast of $100.00 and a low forecast of $14.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Janux Therapeutics in the last twelve months. There are currently 2 sell ratings, 3 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" JANX shares.

According to analysts, Janux Therapeutics's stock has a predicted upside of 223.09% based on their 12-month stock forecasts.

Over the previous 90 days, Janux Therapeutics's stock had 2 upgrades and 2 downgrades by analysts.

Janux Therapeutics has been rated by research analysts at Barclays, Cantor Fitzgerald, Evercore, Guggenheim, JonesTrading, Piper Sandler, Truist Financial, UBS Group, Wedbush, and Weiss Ratings in the past 90 days.

Analysts like Janux Therapeutics more than other "medical" companies. The consensus rating for Janux Therapeutics is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how JANX compares to other companies.


This page (NASDAQ:JANX) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners